BMRA BIOMERICA INC

XNAS 2.31 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

BMRA $2.31 —
Key stats
$2.31
52-Week Range
$1.45 – $3.09
YTD
-8.70%
Straddle Price
$2.15
Market Cap
$0.0B
Open
$1.77
Day Range
$1.66 – $1.79
Volume
7,217
Prev Close
$1.72
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY1.02
Cost of Equity (CAPM)9.81% (VRP-adj)
WACC9.95%
Volatility Risk Premium-64.3pp (IV − HV30), ERP adj -25bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+4.5%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.05 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-137.3%
Book / Price68.9% — banking bias active (P/B is primary)
Gross Margin (TTM)0.9%
FCF Margin (TTM)-91.2%
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$2.05 (Market Anchor value)
SMA 20 / Bollinger Mid$1.91
Bollinger Width / SMA202160.4% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: CLDX, LNTH, MYGN, NEOG, NTLA, QDEL (SIC-code peers; ETF co-membership was sector-incoherent)
60-Day Conviction
60%
20-Day Fair Value
≈ by Nov 25, 2026
$1.73
α +1.4% rank 93%
conviction
73%
40-Day Fair Value
≈ by Dec 24, 2026
$1.76
α +2.9% rank 94%
conviction
84%
60-Day Fair Value
≈ by Jan 22, 2027
$1.74
α +1.8% rank 91%
conviction
60%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0% median 16.6× · 3 peers
Peer P/B $2.36 18% median 2.0× · 6 peers
Peer P/S $5.30 18% median 3.6× · 6 peers
Market Anchor (SMA50) $2.05 64% stability 70% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-10-27 · updated
About
Industry (SIC)
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (2835) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
50
List Date
1978-09-26
CIK
0000073290
Headquarters
Irvine, CA
Homepage
https://www.biomerica.com

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan34.39%2.40%-12.54%-26.19%66.63%-6.13%9.76%
Feb-9.19%2.36%-8.78%34.30%56.20%-13.69%10.20%
Mar-13.20%5.92%-30.48%-30.67%-20.40%4.43%-14.07%
Apr-20.95%-14.57%-28.11%-30.09%-20.61%-0.46%-19.13%
May-22.17%-7.41%1.48%-7.86%-15.28%9.03%-7.04%
Jun9.86%-19.37%6.25%-24.95%-6.78%-25.42%-10.07%
Jul-10.93%-4.81%2.33%-24.81%5.19%-16.53%-8.26%
Aug21.08%27.34%-16.34%46.72%-3.16%36.60%18.71%
Sep-2.17%19.09%-33.32%-23.85%-5.67%8.13%-6.30%
Oct-26.09%-20.53%16.81%10.06%-1.06%-23.50%*-7.39%
Nov8.99%2.35%-0.69%4.70%-12.55%--0.56%
Dec-12.19%-9.46%34.41%-27.12%11.50%---0.57%
Total-46.57%-24.73%-61.73%-76.56%20.42%-35.41%-37.43%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.88
SMA 50: $2.05
SMA 200: $2.06
Current: $1.71
EMA 12: $1.79
EMA 26: $1.91
MACD: -0.1248 | Signal: -0.0177
BEARISH
ADX (14): 27.60
TREND
+DI: 16.21
−DI: 25.56

Momentum Oscillators

RSI (14): 35.24
NEUTRAL
Stoch %K: 23.33
Stoch %D: 18.69
Williams %R: -68.83

Volume & Volatility

BB Upper: $2.24
BB Lower: $1.52
NEUTRAL
OBV: 96,713,431
Vol SMA 20: 12,086
Vol ROC: -45.81%
ATR: $0.12
True Range: $0.13
HV 20: 54.2%
HV 30: 64.2%
HV 60: 73.4%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-29T00:00:00 – 2026-10-27T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary Overall assessment: NEUTRAL (6/10) Key drivers: Oversold RSI, bearish MACD, and range-bound ADX Primary risks: Low volume and volatility, potential for breakouts based on technical signals Investment thesis: BMRA is in a consolidation phase after a recent decline, with oversold momentum indicators hinting at a potential bounce. However, the options market is pricing in a historically low volatility environment, which may limit any significant moves. Recent news sentiment impact: The recent positive news headlines have not had a significant impact on the stock price, suggesting that investors are focused on technical and fundamental factors rather than short-term news events.

Technical Analysis Trend Direction: Short-term (1-4 weeks): Neutral/Range-bound Medium-term (1-3 months): Bearish/Downward trend Long-term (3-12 months): Bearish/Downward trend

Support/Resistance Levels:

  • SMA 20: $2.18
  • Lower Bollinger Band: $1.77

Momentum Signals: RSI interpretation: Oversold (<30), potential buy signal MACD signal: Bearish, potential sell signal Bollinger Bands position: Neutral/Squeeze

Volume Analysis: Volume trend: Low volume and volatility Institutional interest signals: Low open interest in options market

News & Sentiment Analysis Recent Headlines Summary:

  1. Positive news on financial results. 2-5. Neutral/General business announcements.

Sentiment Assessment: Mixed (50% positive, 50% neutral)

Catalyst Identification: None significant in the near term.

Market Narrative: The recent news has not had a significant impact on the stock price, suggesting that investors are focused on technical and fundamental factors rather than short-term news events.

Risk & Volatility Assessment Beta Interpretation: Low risk relative to market (beta <0.8)

Volatility Regime: Historical volatility is low compared to market norms.

Options Market Signals: IV rank: 0.0% (Low - shows if volatility is historically high/low) Current IV: 0.0% Expected Move: $2.15 (0 DTE), 7-DTE: $2.15

Downside Protection: Lower Bollinger Band and SMA 20 provide support.

Market Context & Positioning Sector Performance: Biotech sector is trending upward.

Institutional Activity: Low institutional interest in options market suggests a lack of conviction among institutions.

Correlation Analysis: Stock moves less than market (low correlation).

Relative Valuation: Position within trading range.

Key Levels & Action Items Critical Price Levels:

  • SMA 20: $2.18
  • Lower Bollinger Band: $1.77

Breakout/Breakdown Levels:

  • Upper Bollinger Band: $2.59 (potential resistance)

Time-Sensitive Catalysts: None significant in the near term.

Risk Management: Stop-loss levels and position sizing considerations based on technical signals and risk metrics.

Additional Comments Data Interpretation: RSI >70 oversold (potential buy signal) MACD -0.10 bearish momentum Bollinger Bands neutral squeeze

News Impact Assessment: Positive news has not had a significant impact on the stock price, suggesting that investors are focused on technical and fundamental factors rather than short-term news events.

Risk Assessment Criteria: High Risk: None Medium Risk: Low volume and volatility Low Risk: Historical low volatility and low institutional interest in options market

Generated
News
All BMRA news →
Earnings History
0 of 1 under expected move
Avg Expected Move
3.81%
Avg Actual Move
4.75%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-12-16 unknown 3.81% 4.75% 1.25x Exceeded

Earnings calendar: this week’s reports with expected vs actual moves →

BMRA Options Activity & IV Rank

Volatility Metrics

Current IV: —
7-DTE IV: —
Expected Move: $2.15
7-DTE Move: $2.15
Days to Exp: — (2025-12-19)

Options Flow

Call Volume: 0
Put Volume: 0
P/C Volume: —
Call OI: 0
Put OI: 0
P/C OI: —
Total OI: 0

ATM Options Pricing

ATM Call: $1.07
ATM Put: $1.07
Call %: 46.5%
Put %: 46.5%

Chain Summary

Chain Volume: 0
Chain OI: 0
Last Updated: 12/19/2025
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Sep 15 · No data
30 DTE / 10d —
— pts EXTREME
as of Sep 15 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$2.15Dec 19
Beta Analysis

Risk Metrics

Beta: 0.7400
Alpha: -48.03%
Correlation: 0.1627
R-Squared: 2.6%
Stock Volatility: 57.8%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time

BMRA Institutional Ownership (13F)

Latest filings — 2026-06-30
Diluted shares outstanding: 3,079,233 (as of 2026-08-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

22 filers147,017 shares$274.90K value4.77% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 21,127 $53.24K 19.37% 0.69% 2025-12-31
2 HRT FINANCIAL LP 26,374 $46.00K 16.73% 0.86% 2026-06-30
3 Geode Capital Management, LLC Custodian 24,347 $42.86K 15.59% 0.79% 2026-06-30
4 BlackRock, Inc. Custodian 18,636 $32.80K 11.93% 0.61% 2026-06-30
5 Vanguard Capital Management LLC 14,514 $25.55K 9.29% 0.47% 2026-06-30
6 Jane Street Group, LLC Custodian 12,640 $22.25K 8.09% 0.41% 2026-06-30
7 LPL Financial LLC Custodian 10,849 $19.09K 6.95% 0.35% 2026-06-30
8 UBS Group AG Custodian 6,951 $12.23K 4.45% 0.23% 2026-06-30
9 Vanguard Fiduciary Trust Co 6,613 $11.64K 4.23% 0.21% 2026-06-30
10 NewEdge Advisors, LLC 3,603 $6.34K 2.31% 0.12% 2026-06-30
11 CIBC Private Wealth Group LLC 662 $1.67K 0.61% 0.02% 2025-12-31
12 Tower Research Capital LLC (TRC) Custodian 238 $419 0.15% <0.01% 2026-06-30
13 HOLLENCREST CAPITAL MANAGEMENT 200 $352 0.13% <0.01% 2026-06-30
14 HARBOUR INVESTMENTS, INC. 125 $220 0.08% <0.01% 2026-06-30
15 FMR LLC Custodian 83 $146 0.05% <0.01% 2026-06-30
16 IFG Advisory, LLC 25 $44 0.02% <0.01% 2026-06-30
17 Larson Financial Group LLC 12 $21 <0.01% <0.01% 2026-06-30
18 Barclays PLC Custodian 6 $11 <0.01% <0.01% 2026-06-30
19 MCF Advisors LLC 6 $11 <0.01% <0.01% 2026-06-30
20 Federation des caisses Desjardins du Quebec Custodian 3 $5 <0.01% <0.01% 2026-06-30
21 Caitong International Asset Management Co., Ltd 2 $4 <0.01% <0.01% 2026-06-30
22 DANSKE BANK A/S 1 $2 <0.01% 0.00% 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

BMRA Insider Trading (Form 4)

Latest: 2026-08-27
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-08-27 M. Huff Gary Director Buy (P) +31,250 $1.60 $50.0K EDGAR
2026-08-27 Allen Barbieri Executive Vice Chairman Buy (P) +20,000 $1.60 $32.0K EDGAR
2026-08-27 David Moatazedi Director Buy (P) +10,000 $1.60 $16.0K EDGAR
2026-08-27 Zackary S. Irani Chief Executive Officer Buy (P) +31,250 $1.60 $50.0K EDGAR
2026-08-27 Eric Chin Director Buy (P) +6,250 $1.60 $10.0K EDGAR
2026-01-28 Eric Chin Director Award (A) +22,500 — EDGAR
2025-12-31 Gary Lu Chief Financial Officer Award (A) +40,000 — EDGAR
2025-12-31 M. Huff Gary Director Award (A) +20,000 — EDGAR
2025-12-31 Zackary S. Irani Chief Executive Officer Award (A) +52,500 — EDGAR
2025-12-31 Allen Barbieri Executive Vice-Chairman Award (A) +30,000 — EDGAR
2025-12-31 David Moatazedi Director Award (A) +20,000 — EDGAR
2024-12-17 David Moatazedi Director Award (A) +85,000 $0.31 $26.4K EDGAR
2024-12-17 Jane Emerson Director Award (A) +85,000 $0.31 $26.4K EDGAR
2024-12-17 Catherine Coste Director Award (A) +85,000 $0.31 $26.4K EDGAR
2024-12-17 Allen Barbieri Executive Vice Chairman Award (A) +110,000 $0.31 $34.1K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

BMRA Insider Holdings

8 insiders · @ $1.71
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Zackary S. Irani Chief Executive Officer 242,570 $414.8K $101.0K 33 2026-08-27
2 Allen Barbieri Executive Vice Chairman 73,542 $125.8K $36.5K 15 2026-08-27
3 Gary Lu Chief Financial Officer 59,375 $101.5K $0 4 2025-12-31
4 M. Huff Gary Director 51,250 $87.6K $50.0K 2 2026-08-27
5 David Moatazedi Director 40,625 $69.5K $16.0K 5 2026-08-27
6 Eric Chin Director 38,750 $66.3K $10.0K 2 2026-08-27
7 Jane Emerson Director 19,500 $33.3K $2.8K 11 2024-12-17
8 Catherine Coste Director 17,237 $29.5K $56.1K 7 2024-12-17
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

BMRA Board & Officers

As of SEC filings through Sep 10, 2026

Directors 5

Officers 4

  • Zackary S. Irani · Chief Executive Officer · listed since Jun 2007
  • Gary Lu · Chief Financial Officer · since Mar 1, 2023
  • Allen Barbieri · Executive Vice Chairman · listed since Dec 2024
  • Xiaoxuan Qu · Principal Financial Officer and Principal Accounting Officer · since Aug 27, 2026

10% owners 3

Changes in the last 10 years (21)
Aug 27, 2026Xiaoxuan Qu became Principal Financial Officer and Principal Accounting Officer
Aug 25, 2026Bryant R Riley became a 10% owner
Aug 25, 2026BRC Group Holdings, Inc. became a 10% owner
Aug 25, 2026B. RILEY Principal Capital, LLC became a 10% owner
Dec 31, 2025M. Huff Gary first on file as a director
Oct 7, 2025The company announced the departure of Jane Emerson from the board in an SEC filing
Jun 4, 2025The company announced the departure of Catherine Coste from the board in an SEC filing
Jun 4, 2025Eric Chin became a director
Dec 17, 2024Allen Barbieri listed as Executive Vice Chairman (previously Vice Chairman) in SEC filings
Jun 26, 2024The company announced the departure of John P. Kenny from the board in an SEC filing
Aug 28, 2023John P. Kenny became a director
Mar 1, 2023Gary Lu became Chief Financial Officer
Dec 12, 2022The company announced the departure of Steven Sloan as Chief Financial Officer in an SEC filing
Dec 7, 2022The company announced the departure of Mark A Sirgo from the board in an SEC filing
Dec 7, 2022David Moatazedi became a director
Jun 25, 2021Allen Barbieri first listed as Vice Chairman in an SEC filing
Sep 3, 2020Steven Sloan became Chief Financial Officer
Sep 3, 2020Catherine Coste became a director
Dec 10, 2018Zackary S. Irani no longer listed as a 10% owner in SEC filings
Dec 23, 2016Janet Moore no longer listed as a 10% owner in SEC filings
Not reported recently (3)
  • Francis Cano · Last reported as a director in an SEC filing dated Dec 11, 2020
  • Janet Moore · Last reported as a director in an SEC filing dated Jan 6, 2020
  • Francis E Capitanio · Last reported as President in an SEC filing dated Jan 25, 2018
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
1 ETF hold BMRA
1 shown · $32.80K total exposure
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VXF Vanguard Extended Market ETF Vanguard 0.00% $32,802 — 2026-09-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-1.63
TTM Revenue
$4.34M
TTM Net Income
$-5.01M
TTM Op. Cash Flow
$-3.96M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q1 '272026-08-31$1.26M$-1.23M$-0.37$-802.00K
Q4 '262026-05-31$875.00K$-1.15M$-0.37$-912.00K
Q3 '262026-02-28$987.00K$-1.31M$-0.44$-1.25M
Q2 '262025-11-30$1.21M$-1.32M$-0.45$-991.00K
Q1 '262025-08-31$1.38M$2.00K$0.00$-268.00K
Q4 '252025-05-31$749.00K$-1.54M$-0.61$-662.00K
Q3 '252025-02-28$1.12M$-1.16M$-0.48$-1.04M
Q2 '252024-11-30$1.64M$-950.00K$-0.44$-791.00K
Q1 '252024-08-31$1.81M$-1.32M$-0.63$-1.34M
Q4 '242024-05-31$1.12M$-1.42M$-0.68$-1.04M
Q3 '242024-02-29$1.02M$-1.92M$-0.88$-1.80M
Q2 '242023-11-30$1.57M$-1.51M$-0.72$-842.00K
Q1 2027 • period ending 2026-08-31 • filed 2026-10-15
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.44
P/S
1.21
EV/EBITDA
—
EV/Sales
0.58
ROE
-137.3%
ROA
-62.1%
Div Yield
0.00%
FCF Yield
-75.11%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$5.27M
as of 2026-10-27
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
27.66K
SI % of Float
0.67%
Days to Cover
1.00
Short Vol Ratio
8.5%
Free Float
4.11M
Float %
89.5%
Short interest 2026-09-30 • Short volume 2026-10-27 • Float 2026-08-28